Lakewood, Colorado, November 6, 2019 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today reported record second quarter revenues and adjusted operating income (“AOI”) for the three months ended September 30, 2019. Financial Highlights In comparison to the same quarter in the prior year, second quarter revenues increased 3% to $25.5M,…
DetailsLakewood, Colorado, October 31, 2019 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”), a diversified supplier of quality control instruments and consumables to highly regulated markets today announced the acquisition of Gyros Protein Technologies Holding AB (“GPT”). GPT is headquartered in Uppsala, Sweden and is a leading provider of Immunoassay and…
DetailsMesa Labs Announces Changes in The Composition of Its Board of Directors Lakewood, Colorado, March 06, 2019 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) has announced several changes to the composition of its Board of Directors (the “Board”). As previously announced, on January 23, 2019 David B. Perez was appointed…
Details